Chami, Goylette F. Ahnert, Sebastian E. Kabatereine, Narcis B. and Tukahebwa, Edridah M. 2017. Social network fragmentation and community health. Proceedings of the National Academy of Sciences, Vol. 114, p. E7425.
Campbell, Suzy J. Stothard, J. Russell O’Halloran, Faye Sankey, Deborah Durant, Timothy Ombede, Dieudonné Eloundou Chuinteu, Gwladys Djomkam Webster, Bonnie L. Cunningham, Lucas LaCourse, E. James and Tchuem-Tchuenté, Louis-Albert 2017. Urogenital schistosomiasis and soil-transmitted helminthiasis (STH) in Cameroon: An epidemiological update at Barombi Mbo and Barombi Kotto crater lakes assessing prospects for intensified control interventions. Infectious Diseases of Poverty, Vol. 6,
BUSTINDUY, AMAYA L. WRIGHT, STEPHEN JOEKES, ELIZABETH C. KABATEREINE, NARCIS B. REINHARD-RUPP, JUTTA KING, CHARLES H. and STOTHARD, J. RUSSELL 2017. One hundred years of neglect in paediatric schistosomiasis. Parasitology, Vol. 144, p. 1613.
Shen, Ye King, Charles H. Binder, Sue Zhang, Feng Whalen, Christopher C. Evan Secor, W. Montgomery, Susan P. Mwinzi, Pauline N. M. Olsen, Annette Magnussen, Pascal Kinung’hi, Safari Phillips, Anna E. Nalá, Rassul Ferro, Josefo Aurelio, H. Osvaldo Fleming, Fiona Garba, Amadou Hamidou, Amina Fenwick, Alan Campbell, Carl H. and Colley, Daniel G. 2017. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries. BMC Infectious Diseases, Vol. 17,
Manz, Kirsi M. Clowes, Petra Kroidl, Inge Kowuor, Dickens O. Geldmacher, Christof Ntinginya, Nyanda E. Maboko, Leonard Hoelscher, Michael Saathoff, Elmar and Diemert, David Joseph 2017. Trichuris trichiura infection and its relation to environmental factors in Mbeya region, Tanzania: A cross-sectional, population-based study. PLOS ONE, Vol. 12, p. e0175137.
Bustinduy, Amaya L. Stothard, J. Russell and Friedman, Jennifer F. 2017. Paediatric and maternal schistosomiasis: shifting the paradigms. British Medical Bulletin, Vol. 123, p. 115.
Stanton, Michelle C. Adriko, Moses Arinaitwe, Moses Howell, Alison Davies, Juliet Allison, Gillian LaCourse, E. James Muheki, Edridah Kabatereine, Narcis B. and Stothard, J. Russell 2017. Intestinal schistosomiasis in Uganda at high altitude (>1400 m): malacological and epidemiological surveys on Mount Elgon and in Fort Portal crater lakes reveal extra preventive chemotherapy needs. Infectious Diseases of Poverty, Vol. 6,
Lamberton, Poppy H.L. Faust, Christina L. and Webster, Joanne P. 2017. Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study. Infectious Diseases of Poverty, Vol. 6,
Knowles, Sarah C. L. Sturrock, Hugh J. W. Turner, Hugo Whitton, Jane M. Gower, Charlotte M. Jemu, Samuel Phillips, Anna E. Meite, Aboulaye Thomas, Brent Kollie, Karsor Thomas, Catherine Rebollo, Maria P. Styles, Ben Clements, Michelle Fenwick, Alan Harrison, Wendy E. Fleming, Fiona M. and Bethony, Jeffrey Michael 2017. Optimising cluster survey design for planning schistosomiasis preventive chemotherapy. PLOS Neglected Tropical Diseases, Vol. 11, p. e0005599.
Kabuyaya, Muhubiri Chimbari, Moses John Manyangadze, Tawanda and Mukaratirwa, Samson 2017. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa. Infectious Diseases of Poverty, Vol. 6,
Kalinda, Chester Chimbari, Moses and Mukaratirwa, Samson 2017. Implications of Changing Temperatures on the Growth, Fecundity and Survival of Intermediate Host Snails of Schistosomiasis: A Systematic Review. International Journal of Environmental Research and Public Health, Vol. 14, p. 80.
King, Charles H. and Walson, Judd L. 2017. The evolving schistosomiasis agenda 2007-2017—Why we are moving beyond morbidity control toward elimination of transmission. PLOS Neglected Tropical Diseases, Vol. 11, p. e0005517.
Tchuem Tchuenté, Louis-Albert Rollinson, David Stothard, J. Russell and Molyneux, David 2017. Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies. Infectious Diseases of Poverty, Vol. 6,
Singh, Raghvendra Yadav, Birendra Singh Singh, Swati Pandey, Paras Nath and Mani, Ashutosh 2016. In-silico screening of Schistosoma mansoni Sirtuin1 inhibitors for prioritization of drug candidates. SpringerPlus, Vol. 5,
Deol, Arminder Webster, Joanne P. Walker, Martin Basáñez, Maria-Gloria Hollingsworth, T. Déirdre Fleming, Fiona M. Montresor, Antonio and French, Michael D. 2016. Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali. Parasites & Vectors, Vol. 9,
Silveira, Alda Maria Soares Costa, Emanuele Gama Dutra Ray, Debalina Suzuki, Brian M. Hsieh, Michael H. Fraga, Lucia Alves de Oliveira Caffrey, Conor R. and Secor, William Evan 2016. Evaluation of the CCA Immuno-Chromatographic Test to Diagnose Schistosoma mansoni in Minas Gerais State, Brazil. PLOS Neglected Tropical Diseases, Vol. 10, p. e0004357.
Manyangadze, Tawanda Chimbari, Moses John Gebreslasie, Michael and Mukaratirwa, Samson 2016. Risk factors and micro-geographical heterogeneity of Schistosoma haematobium in Ndumo area, uMkhanyakude district, KwaZulu-Natal, South Africa. Acta Tropica, Vol. 159, p. 176.
Singh, Raghvendra Singh, Swadha and Pandey, Paras Nath 2016. In-silicoanalysis of Sirt2 fromSchistosoma mansoni: structures, conformations, and interactions with inhibitors. Journal of Biomolecular Structure and Dynamics, Vol. 34, p. 1042.
Schistosomiasis remains one of the most prevalent parasitic diseases in developing countries. After malaria, schistosomiasis is the most important tropical disease in terms of human morbidity with significant economic and public health consequences. Although schistosomiasis has recently attracted increased focus and funding for control, it has been estimated that less than 20% of the funding needed to control the disease in Africa is currently available. In this article the following issues are discussed: the rationale, development and objectives of the Schistosomiasis Control Initiative (SCI)-supported programmes; the management approaches followed to achieve implementation by each country; mapping, monitoring and evaluation activities with quantifiable impact of control programmes; monitoring for any potential drug resistance; and finally exit strategies within each country. The results have demonstrated that morbidity due to schistosomiasis has been reduced by the control programmes. While challenges remain, the case for the control of schistosomiasis has been strengthened by research by SCI teams and the principle that a national programme using ‘preventive chemotherapy’ can be successfully implemented in sub-Saharan Africa, whenever the resources are available. SCI and partners are now actively striving to raise further funds to expand the coverage of integrated control of neglected tropical diseases (NTDs) in sub-Saharan Africa.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
* Views captured on Cambridge Core between September 2016 - 18th October 2017. This data will be updated every 24 hours.